Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Medivation Inc (NASDAQ:MDVN)

81.42
Delayed Data
As of Sep 23
 +0.34 / +0.42%
Today’s Change
26.41
Today|||52-Week Range
81.45
+68.43%
Year-to-Date
New Setback for Sanofi's Lantus Increases Need for M&A
Sep 22 / TheStreet.com - Paid Partner Content
Zacks.com featured highlights: PTC, Capital Senior Living, ZELTIQ Aesthetics, Conns a...
Sep 16 / Zacks.com - Paid Partner Content
Sanofi Sues Merck Over Patent Infringement
Sep 20 / GuruFocus News - Paid Partner Content
5 Toxic Stocks to Offload or Play Short
Sep 15 / Zacks.com - Paid Partner Content
Sanofi in a State of Suspended Animation Until Boehringer Ingelheim Swap
Sep 19 / GuruFocus News - Paid Partner Content
Why Pfizer's Stock Is a Big Gamble Right Now
Sep 13 / MotleyFool.com - Paid Partner Content
Pfizer: Hospira Is Future; Xtandi Is Today's Meal
Sep 19 / GuruFocus News - Paid Partner Content
2 Biotech Stocks that Turned $8,000 into over $250,000
Sep 12 / MotleyFool.com - Paid Partner Content
Forget Novavax, Buy These 4 Biotech Stocks Instead
Sep 16 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close81.08
Today’s open81.43
Day’s range81.40 - 81.45
Volume16,114,557
Average volume (3 months)3,624,253
Market cap$13.5B
Dividend yield--
Data as of 3:59pm ET, 09/23/2016

Growth & Valuation

Earnings growth (last year)-15.48%
Earnings growth (this year)-13.84%
Earnings growth (next 5 years)+35.00%
Revenue growth (last year)+32.76%
P/E ratioNM
Price/Sales8.68
Price/Book15.29

Competitors

 Today’s
change
Today’s
% change
PRGOPerrigo Company PLC+0.28+0.29%
BMRNBiomarin Pharmaceuti...-0.05-0.05%
INCYIncyte Corp-0.29-0.32%
VRXValeant Pharmaceutic...+0.87+3.24%
Data as of 4:02pm ET, 09/23/2016

Financials

Next reporting dateNovember 3, 2016
EPS forecast (this quarter)$0.30
Annual revenue (last year)$943.3M
Annual profit (last year)$244.7M
Net profit margin25.94%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
David T. Hung
Chief Operating Officer
Marion McCourt
Corporate headquarters
San Francisco, California

Forecasts

Search for Jobs